kevin hughes , of canvey , essex , took part in clinical trials of abiraterone to treat his prostate cancer .
mr hughes was given three years to live after being diagnosed with advanced prostate cancer last april .
the drug is currently available on the nhs to men who have already gone through chemotherapy .